MARKET

CUBT

CUBT

Curative Biotechnology Inc
OTCID
1.360
-0.140
-9.33%
Closed 10:50 05/29 EDT
OPEN
1.360
PREV CLOSE
1.500
HIGH
1.360
LOW
1.360
VOLUME
100
TURNOVER
136
52 WEEK HIGH
2.100
52 WEEK LOW
0.031
MARKET CAP
10.42M
P/E (TTM)
-0.8611
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CUBT last week (0518-0522)?
Weekly Report · 6d ago
Weekly Report: what happened at CUBT last week (0511-0515)?
Weekly Report · 05/18 09:35
Weekly Report: what happened at CUBT last week (0504-0508)?
Weekly Report · 05/11 09:34
Weekly Report: what happened at CUBT last week (0427-0501)?
Weekly Report · 05/04 09:33
Weekly Report: what happened at CUBT last week (0420-0424)?
Weekly Report · 04/27 09:34
Weekly Report: what happened at CUBTD last week (0413-0417)?
Weekly Report · 04/20 09:32
Weekly Report: what happened at CUBTD last week (0406-0410)?
Weekly Report · 04/13 09:34
Weekly Report: what happened at CUBTD last week (0330-0403)?
Weekly Report · 04/06 09:34
More
About CUBT
Curative Biotechnology, Inc. is a development stage biomedical company focused on therapies for rare diseases. The Company is identifying, acquiring, and developing disease modifying therapeutic drug candidates with a concentration on rare disease indications. It has ongoing programs in three different therapeutic areas: degenerative eye disease, infectious disease, and neuro-oncology. It is primarily focused on its degenerative eye disease platform. The first therapeutic to be developed on this platform is a Metformin Reformulation targeting the treatment of intermediate and late-stage age-related macular degeneration (AMD) disease. Its development pipeline is focused on three therapeutic areas: degenerative eye disease, infectious disease, and neuro oncology. IMT504 is an oligodeoxynucleotide (ODN). ODNs are synthetic molecules that stimulate different kinds of cells of immune system of animals and humans.

Webull offers Curative Biotechnology Inc stock information, including OTCID: CUBT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CUBT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CUBT stock methods without spending real money on the virtual paper trading platform.